Status:

TERMINATED

Compression Headphone Study

Lead Sponsor:

Sonova AG

Collaborating Sponsors:

Sonova Canada Inc.

Conditions:

Hearing Loss

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

The stimuli consist of speech in quiet, speech in noise, reverberant speech, and music recorded with different hearing aid settings, post-processed for headphone presentation and incorporated in an on...

Eligibility Criteria

Inclusion

  • Adults (18-99 years) with ≥3 months hearing aid experience
  • binaural, symmetric, sensorineural N3 to N4 hearing loss
  • able to use Android interface and receive a video call on phone/computer
  • fluent in English

Exclusion

  • children/teenagers
  • normal hearing or hearing loss exceeding N4 by 10dB
  • cannot wear over-ear headphones

Key Trial Info

Start Date :

May 10 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 2 2021

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04882709

Start Date

May 10 2021

End Date

September 2 2021

Last Update

August 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sonova Innovation Centre Toronto

Mississauga, Ontario, Canada, L5L1J3